Who owns KEZAR LIFE SCIENCES INC?
- Ticker: KZR
- CUSIP Number: 49372l209
Tip: Access positions for across all investors
Analyze quarterly positions in Kezar Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kezar Life Sciences stock
Who bought or sold KEZAR LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 721k | $4.5M | 0% | Dec 2025 |
|
| Suvretta Capital Management | 717k | $4.5M | 0% | Dec 2025 |
|
| Tang Capital Management | 664k | $4.2M | -8% | Dec 2025 |
|
| Vanguard Group | 341k | $2.1M | 27% | Dec 2025 |
|
| Nantahala Capital Management | 277k | $1.7M | 100% | Dec 2025 |
|
| Affinity Asset Advisors | 229k | $1.4M | 100% | Dec 2025 |
|
| Stonepine Capital Management | 156k | $982k | -59% | Dec 2025 |
|
| Renaissance Technologies | 131k | $826k | 13% | Dec 2025 |
|
| Peapod Lane Capital | 127k | $797k | 1% | Dec 2025 |
|
| Acadian Asset Management | 125k | $787k | -6% | Dec 2025 |
|
| Susquehanna International | 119k | $747k | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 117k | $739k | -6% | Dec 2025 |
|
| Ikarian Capital | 102k | $643k | -4% | Dec 2025 |
|
| BlackRock | 99k | $621k | 1% | Dec 2025 |
|
| Rangeley Capital | 86k | $541k | 100% | Dec 2025 |
|
| Qiming U.S. Ventures Management | 83k | $323k | 0% | Sep 2025 |
|
| Aldebaran Capital | 81k | $507k | 100% | Dec 2025 |
|
| Geode Capital Management | 68k | $429k | 4% | Dec 2025 |
|
| Two Sigma Advisers | 54k | $212k | -1% | Sep 2025 |
|
| FNY Investment Advisers | 50k | $314k | 100% | Dec 2025 |
|
| Vazirani Asset Management | 48k | $305k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 41k | $160k | 0% | Sep 2025 |
|
| Citadel Advisors | 34k | $132k | 100% | Sep 2025 |
|
| None | 34k | $212k | 100% | Dec 2025 |
|
| Rbf Capital | 28k | $110k | 0% | Sep 2025 |
|
| State Street Corporation | 27k | $170k | 28% | Dec 2025 |
|
| Dimensional Fund Advisors | 27k | $167k | 14% | Dec 2025 |
|
| Nano Cap New Millennium Growth Fund | 25k | $157k | 100% | Dec 2025 |
|
| Two Sigma Investments | 24k | $92k | -5% | Sep 2025 |
|
| Torno Capital | 20k | $126k | 100% | Dec 2025 |
|
| Boothbay Fund Management | 16k | $102k | -22% | Dec 2025 |
|
| Northern Trust | 14k | $87k | -1% | Dec 2025 |
|
| FMR | 8.7k | $34k | -61% | Sep 2025 |
|
| Wells Fargo & Company | 5.8k | $37k | 0% | Dec 2025 |
|
| Global Retirement Partners | 1.0k | $6.3k | 0% | Dec 2025 |
|
| Tower Research Capital | 564.00 | $3.5k | -52% | Dec 2025 |
|
| Jpmorgan Chase & Co | 209.00 | $814.995500 | 100% | Sep 2025 |
|
| Atlantic Trust | 100.00 | $629.000000 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 94.00 | $590.996800 | 4% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 89.00 | $559.996900 | -7% | Dec 2025 |
|
| Hanson McClain Advisors | 50.00 | $315.000000 | 100% | Dec 2025 |
|
| UBS Group | 40.00 | $252.308000 | -89% | Dec 2025 |
|
| Barclays | 1.00 | $6.000000 | 0% | Dec 2025 |
|
Who sold out of Kezar Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OrbiMed Advisors | Sep 2025 | 193k | $752k |
| Shay Capital | Sep 2025 | 68k | $264k |
| Millennium Management | Jun 2025 | 26k | $118k |
| Landscape Capital Management | Sep 2025 | 13k | $51k |